Faheem Hasnain's Net Worth
$31.8 Million
Who is Faheem Hasnain?
Faheem Hasnain has an estimated net worth of $31.8 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., TERCICA INC, FACET BIOTECH CORP, Nuvation Bio Inc., Receptos, Inc., Mirati Therapeutics, Inc., Kura Oncology, Inc., VITAL THERAPIES INC, Gossamer Bio, Inc., Tocagen Inc, PDL BIOPHARMA, INC., AMBIT BIOSCIENCES CORP, and Pernix Sleep, Inc..
SEC CIK
Faheem Hasnain's CIK is 0001352620
Past Insider Trading and Trends
2023 was Faheem Hasnain's most active year for acquiring shares with 12 total transactions. Faheem Hasnain's most active month to acquire stocks was the month of January. 2008 was Faheem Hasnain's most active year for disposing of shares, totalling 33 transactions. Faheem Hasnain's most active month to dispose stocks was the month of March. 2017 saw Faheem Hasnain paying a total of $2,276,440.40 for 343,170 shares, this is the most they've acquired in one year. In 2015 Faheem Hasnain cashed out on 799,849 shares for a total of $80,664,086.13, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $241.48
EVP, Oncology/Rheumatology SBU
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -20.74% | -6.66K |
$53.97 | -$902,357.30 | 25.45K |
Scheduled
|
Jul 9
| ||
Form 4
| -16.67% | -6.42K |
$64.47 | -$414,207.94 | 32.12K |
Scheduled
|
Apr 8
| ||
Form 4
| +29.36% | 8.64K |
$60.56 | -$108,281.28 | 38.08K |
Feb 12
| |||
Form 4
| +13.28% | 3.45K |
$60.52 | -$122,068.84 | 29.43K |
Feb 6
| |||
Form 4
| +11.63% | 2.7K |
—
|
—
| 25.92K |
Nov 1
| |||
Form 4
| -13.45% | -3.58K |
$65.88 | -$235,521.00 | 23.01K |
Oct 4
| |||
Form 4/A
| -22.13% | -7.45K |
$49.00 | -$364,854.00 | 26.21K |
Scheduled
|
May 23
| ||
Form 4
| -22.33% | -7.45K |
$49.00 | -$364,854.00 | 25.9K |
Scheduled
|
May 23
| ||
Form 4
| +13.63% | 4K |
$44.11 | -$98,188.86 | 33.34K |
Mar 14
| |||
Form 4
| +13.63% | 4K |
$44.11 | -$98,188.86 | 33.34K |
Mar 14
| |||
Form 4
| +104.57% | 15K |
—
|
—
| 29.34K |
Feb 12
| |||
Form 4
| +31.63% | 3.45K |
$48.94 | -$98,858.80 | 14.34K |
Feb 6
| |||
Form 4
| -51.02% | -11.24K |
$44.63 | -$501,766.80 | 10.79K |
Scheduled
|
Oct 2
| ||
Form 4
| +105.05% | 11.24K |
$43.39 | -$271,447.84 | 21.95K |
Sep 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TERCICA INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FACET BIOTECH CORP No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -102.67K |
$27.00 | -$2,772,009.00 |
0
|
Apr 21
| |||
Form 4
| -15.24% | -18.46K |
$27.00 | -$498,501.00 | 102.67K |
Apr 20
| |||
Form 4
| -6.94% | -8.94K |
$17.37 | -$155,235.69 | 119.93K |
Oct 1
| |||
Form 4
| +27.67% | 27.67K |
—
|
—
| 127.67K |
Aug 6
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nuvation Bio Inc. (NUVB) Snapshot price: $1.635
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 55K |
$10.00 | $300,000.00 | 55K |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Receptos, Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -416.91K |
—
|
—
|
0
|
Aug 25 - Aug 27
| |||
Form 4
| +8.45% | 32.5K |
—
|
—
| 416.91K |
Apr 1
| |||
Form 4
| -34.05% | -200.00K |
$109.47 | -$21,893,756.50 | 387.41K |
Scheduled
|
Nov 10 - Nov 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
| +8.87% | 47.62K |
$5.25 | $249,994.50 | 584.41K |
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||